ClearPoint Neuro Inc
ClearPoint Neuro Inc (CLPT) Covered Calls
ClearPoint Neuro Inc trades in the Medical Devices industry with an IV Rank of 21.03%, low versus the past year. CLPT's highest covered call setup is the $12.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 41.51% out of the money with 35 days to expiration, a 42.69% return until expiration, and a 445.18% theoretical annualized return. Across the setups shown, annualized returns run from 122.14% to 445.18% at strikes between $9.00 and $17.50, with 7 to 154 days to expiration, as of Nov 13, 2026.
Read more
Running CLPT covered calls helps you generate income from ClearPoint Neuro Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CLPT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If CLPT stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CLPT covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CLPT covered call is worth writing.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco.
| 2026-12-18 | 35 | 12.00 | 41.51 | 0.10 | 0.65 | 362.00 | 42.69 | 445.18 | -1.18 | +0.24 | 44 | 0.55 |
| 2026-11-20 | 7 | 9.00 | 6.13 | 0.10 | 0.90 | 62.00 | 7.31 | 381.23 | -1.18 | +0.43 | 5 | 0.80 |
| 2027-01-15 | 63 | 12.50 | 47.41 | 0.15 | 0.35 | 417.00 | 49.17 | 284.90 | -1.77 | +0.18 | 441 | 0.20 |
| 2027-04-16 | 154 | 17.50 | 106.37 | 0.10 | 0.95 | 912.00 | 107.55 | 254.90 | -1.18 | +0.22 | 104 | 0.85 |
| 2026-12-18 | 35 | 10.00 | 17.92 | 0.10 | 0.75 | 162.00 | 19.10 | 199.23 | -1.18 | +0.32 | 10 | 0.65 |
| 2027-04-16 | 154 | 15.00 | 76.89 | 0.20 | 0.80 | 672.00 | 79.25 | 187.82 | -2.36 | +0.23 | 363 | 0.60 |
| 2027-01-15 | 63 | 11.00 | 29.72 | 0.15 | 0.80 | 267.00 | 31.49 | 182.42 | -1.77 | +0.30 | 0 | 0.65 |
| 2027-04-16 | 154 | 14.00 | 65.09 | 0.20 | 1.05 | 572.00 | 67.45 | 159.87 | -2.36 | +0.28 | 50 | 0.85 |
| 2027-01-15 | 63 | 10.00 | 17.92 | 0.50 | 0.90 | 202.00 | 23.82 | 138.01 | -5.90 | +0.40 | 63 | 0.40 |
| 2027-04-16 | 154 | 12.50 | 47.41 | 0.35 | 1.30 | 437.00 | 51.53 | 122.14 | -4.13 | +0.35 | 129 | 0.95 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV Rank21.03% Low
- Market cap (M$)266
- 52 weeks high-57.72%
- 52 weeks low0.36%
- Analyst recommendationStrong Buy
1.00 - Target price$21.50
170.44% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-10-28
- P/E—
- Future P/E—
- EPS (ttm)-1.21
- EPS growth next 5 years1.50%
As of Nov 16, 2026